Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hemiballismus.

Kathleen M Shannon1

  • 1Neurological Sciences, Rush University Medical Center, 1725 West Harrison Street, Suite 755, Chicago, IL 60612, USA. Kathleen_M_Shannon@rush.edu.

Current Treatment Options in Neurology
|April 9, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Workplace Lactation in Neurology: Barriers and Opportunities.

Neurology. Clinical practice·2026
Same author

Systematic Review with Meta-Analysis of Biofluid Markers for Huntington's Disease.

Movement disorders : official journal of the Movement Disorder Society·2025
Same author

International Parkinson and Movement Disorder Society Viewpoint on Biological Frameworks of Parkinson's Disease: Current Status and Future Directions.

Movement disorders : official journal of the Movement Disorder Society·2024
Same author

Infections and Changes in Commensal Bacteria and the Pathogenesis of Parkinson's Disease.

Journal of Parkinson's disease·2022
Same author

Gut-Derived Sterile Inflammation and Parkinson's Disease.

Frontiers in neurology·2022
Same author

Experimental colitis promotes sustained, sex-dependent, T-cell-associated neuroinflammation and parkinsonian neuropathology.

Acta neuropathologica communications·2021
Same journal

Visual Impairment and Driving in Older Adults: A Narrative Review.

Current treatment options in neurology·2026
Same journal

Non-Cognitive Symptoms in Alzheimer's Disease and Their Likely Impact on Patient Outcomes. A Scoping Review.

Current treatment options in neurology·2026
Same journal

Update on the Treatment of Autonomic Disorders.

Current treatment options in neurology·2025
Same journal

Primary Progressive Aphasia Treatment: Current Treatment Options in Neurology Article Topic: Management of Primary Progressive Aphasia.

Current treatment options in neurology·2025
Same journal

Emerging Principles for Treating Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD).

Current treatment options in neurology·2025
Same journal

Diagnosis and Management of Progressive Corticobasal Syndrome.

Current treatment options in neurology·2025
See all related articles

Hemiballismus, a dramatic movement disorder, arises from subthalamic nucleus dysfunction. Treatment involves addressing the cause and managing ballistic movements with medications or surgery.

Area of Science:

  • Neurology
  • Movement Disorders

Background:

  • Hemiballismus is characterized by violent, involuntary limb movements.
  • It typically indicates a structural or metabolic issue affecting the subthalamic nucleus or related pathways.
  • Causes vary by age, including vascular events in the elderly and infections/inflammation in younger individuals.

Purpose of the Study:

  • To review the etiology, clinical presentation, and management of hemiballismus.
  • To discuss current therapeutic strategies for controlling ballistic movements.
  • To highlight the importance of treating the underlying cause.

Main Methods:

  • Review of clinical literature on hemiballismus.
  • Discussion of pharmacologic treatments including dopamine receptor blockers, neuroleptics, atypical antipsychotics, and catecholamine-depleting agents.

Related Experiment Videos

  • Consideration of surgical interventions for persistent cases.

    • Main Results:

    • Dopamine receptor blocking agents are effective first-line treatments for acute hemiballismus.
    • Atypical antipsychotics may offer a reduced risk of side effects.
    • Long-term management may involve catecholamine-depleting agents.
    • Surgical options exist for refractory cases.

    Conclusions:

    • Hemiballismus management requires addressing both the underlying cause and the hyperkinetic movements.
    • Pharmacotherapy, primarily with dopamine receptor blockers, is the mainstay of acute treatment.
    • Prognosis depends on the underlying etiology, with movements often subsiding over time, allowing medication withdrawal.